Akademik Veri Yönetim Sistemi
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, cilt.25, sa.1, ss.115-122, 2001 (SCI-Expanded)
Metronidazole and miconazole nitrate in ovules was determined by ratio spectra derivative spectrophotometry and by high-performance liquid chromatography (HPLC). The first method depends on ratio spectra first derivative spectrophotometry, by utilizing the linear relationship between substances concentration and ratio spectra first derivative peak amplitude. The ratio first derivative amplitudes at 242.6 ((DD242.6)-D-1), 274.2 ((DD274.2)-D-1), 261.8 ((DD261.8)-D-1), 273.5 ((DD273.5)-D-1) and 281.5 ((DD281.5)-D-1) nm were selected for the assay of metronidazole and miconazole nitrate. respectively. The second method is based on high-performance liquid chromatography on a reversed-phase column using a mobile phase of methanol-water phosphoric acid (30:70:0.20 v/v) (pH 2.8) with programmable detection at 220.0 nm. The minimum concentration detectable by HPLC was 0.9 mug ml(-1) for metronidazole and 0.3 mug ml(-1) for miconazole nitrate and by ratio derivative spectrophotometry 4.0 mug ml(-1) for metronidazole and 0.5 mug ml(-1) for miconazole nitrate. The proposed procedures were successfully applied to the simultaneous determination of metronidazole and miconazole nitrate in ovules with a high percentage of recovery, good accuracy and precision. (C) 2001 Elsevier Science B.V. All rights reserved.